Experimental Validation of a Theoretical Model of Cytokine Capture Using a Hemoadsorption Device

Overview

Journal Ann Biomed Eng

Specialty Biomedical Engineering

Date 2009 Aug 15

PMID 19680812

Citations 4

Authors

Morgan V DiLeo

James D Fisher

William J Federspiel

Affiliations

Soon will be listed here.

Abstract

Sepsis, a systemic inflammatory response in the presence of an infection, is characterized by overproduction of inflammatory mediators called cytokines. Removal of these cytokines using an extracorporeal hemoadsorption device is a potential therapy for sepsis. We are developing a cytokine adsorption device (CAD) filled with microporous polymer beads and have previously published a mathematical model which predicts the time course of cytokine removal by the device. The goal of this study was to show that the model can experimentally predict the rate of cytokine capture associated with key design and operational parameters of the CAD. We spiked IL-6, IL-10, and TNF into horse serum and perfused it through an appropriately scaled-down CAD and measured the change in concentration of the cytokines over time. These data were fit to the mathematical model to determine a single model parameter, Gamma( i ), which is only a function of the cytokine-polymer interaction and the cytokine effective diffusion coefficient in the porous matrix. We compared Gamma( i ) values, which by definition should not change between experiments. Our results indicate that the Gamma( i ) value for a specific cytokine was statistically independent of all other parameters in the model, including initial cytokine concentration, flow rate, serum reservoir volume, CAD size, and bead size. Our results also indicate that competitive adsorption of cytokines and other middle-molecular weight proteins, which is neglected in the model, does not affect the rate of removal of a given cytokine. The model of cytokine capture in the CAD developed in this study will be integrated with a systems model of sepsis to simulate the progression of sepsis in humans and to develop a therapeutic CAD design and intervention protocol that improves patient outcomes in sepsis.

Citing Articles

Modeling and Hemofiltration Treatment of Acute Inflammation.

Parker R, Hogg J, Roy A, Kellum J, Rimmele T, Daun-Gruhn S Processes (Basel). 2020; 4(4):38.

PMID: 33134139 PMC: 7596788. DOI: 10.3390/pr4040038.

Modeling competitive cytokine adsorption dynamics within hemoadsorption beads used to treat sepsis.

Kimmel J, Harbert E, Parker R, Federspiel W J Chromatogr A. 2011; 1218(44):8013-20.

PMID: 21962329 PMC: 3271437. DOI: 10.1016/j.chroma.2011.09.007.

Selective improvement of tumor necrosis factor capture in a cytokine hemoadsorption device using immobilized anti-tumor necrosis factor.

DiLeo M, Fisher J, Burton B, Federspiel W J Biomed Mater Res B Appl Biomater. 2010; 96(1):127-33.

PMID: 21086427 PMC: 3221482. DOI: 10.1002/jbm.b.31748.

IL-6 adsorption dynamics in hemoadsorption beads studied using confocal laser scanning microscopy.

Kimmel J, Gibson G, Watkins S, Kellum J, Federspiel W J Biomed Mater Res B Appl Biomater. 2009; 92(2):390-6.

PMID: 19904819 PMC: 2824169. DOI: 10.1002/jbm.b.31527.

References

Song M, Winchester J, Albright R, Capponi V, Choquette M, Kellum J . Cytokine removal with a novel adsorbent polymer. Blood Purif. 2004; 22(5):428-34. DOI: 10.1159/000080235. View

Lewus R, Carta G . Protein diffusion in charged polyacrylamide gels. Visualization and analysis. J Chromatogr A. 2000; 865(1-2):155-68. DOI: 10.1016/s0021-9673(99)00862-6. View

Angus D, Lidicker J, Clermont G, Carcillo J, Pinsky M . Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29(7):1303-10. DOI: 10.1097/00003246-200107000-00002. View

Hotchkiss R, KARL I . Cytokine blockade in sepsis--Are two better than one?. Crit Care Med. 2001; 29(3):671-2. DOI: 10.1097/00003246-200103000-00040. View

DiLeo M, Kellum J, Federspiel W . A simple mathematical model of cytokine capture using a hemoadsorption device. Ann Biomed Eng. 2008; 37(1):222-9. PMC: 2758484. DOI: 10.1007/s10439-008-9587-8. View

Schroder M, von Lieres E, Hubbuch J . Direct quantification of intraparticle protein diffusion in chromatographic media. J Phys Chem B. 2006; 110(3):1429-36. DOI: 10.1021/jp0542726. View

Kellum J, Dishart M . Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats. Crit Care. 2002; 6(5):429-33. PMC: 130143. DOI: 10.1186/cc1528. View

Peng Z, Carter M, Kellum J . Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med. 2008; 36(5):1573-7. PMC: 3547590. DOI: 10.1097/CCM.0b013e318170b9a7. View

Daun S, Rubin J, Vodovotz Y, Roy A, Parker R, Clermont G . An ensemble of models of the acute inflammatory response to bacterial lipopolysaccharide in rats: results from parameter space reduction. J Theor Biol. 2008; 253(4):843-53. DOI: 10.1016/j.jtbi.2008.04.033. View

10.

Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6):1644-55. DOI: 10.1378/chest.101.6.1644. View

11.

Kellum J . Immunomodulation in sepsis: the role of hemofiltration. Minerva Anestesiol. 1999; 65(6):410-8. View

12.

Bassingthwaighte J . A practical extension of hydrodynamic theory of porous transport for hydrophilic solutes. Microcirculation. 2006; 13(2):111-8. PMC: 3420965. DOI: 10.1080/10739680500466384. View

13.

Kellum J, Kong L, Fink M, Weissfeld L, Yealy D, Pinsky M . Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007; 167(15):1655-63. PMC: 4495652. DOI: 10.1001/archinte.167.15.1655. View

14.

BERGGARD I, Bearn A . Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids. J Biol Chem. 1968; 243(15):4095-103. View

15.

Bellomo R, Tipping P, Boyce N . Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med. 1993; 21(4):522-6. DOI: 10.1097/00003246-199304000-00011. View

16.

Cross A, Opal S . A new paradigm for the treatment of sepsis: is it time to consider combination therapy?. Ann Intern Med. 2003; 138(6):502-5. DOI: 10.7326/0003-4819-138-6-200303180-00016. View

17.

Baue A . Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets?. Arch Surg. 1997; 132(7):703-7. DOI: 10.1001/archsurg.1997.01430310017002. View

18.

Grau G, Maennel D . TNF inhibition and sepsis -- sounding a cautionary note. Nat Med. 1997; 3(11):1193-5. DOI: 10.1038/nm1197-1193. View

19.

Gutenwik J, Nilsson B, Axelsson A . Effect of hindered diffusion on the adsorption of proteins in agarose gel using a pore model. J Chromatogr A. 2004; 1048(2):161-72. View

20.

Kellum J, Song M, Venkataraman R . Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med. 2004; 32(3):801-5. DOI: 10.1097/01.ccm.0000114997.39857.69. View